SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mangalam Drugs & Organics informs about company updates

28 Sep 2017 Evaluate

In accordance with the Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mangalam Drugs & Organics has informed about the details of voting results along with Scrutinizers Report on remote e-voting and voting through Polling papers for the 44th Annual General Meeting of the Company held on September 26, 2017.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

27.72 0.60 (2.21%)
09-Jul-2026 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1940.55
Dr. Reddys Labs. 1268.00
Cipla 1443.00
Zydus Lifesciences 1159.50
Lupin 2501.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: